Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Refractory Diabetic Macular Edema
NCT00505947Phase 3Terminated
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jul 2007
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in diabetic macular edema (DME), sponsored by National and Kapodistrian University of Athens. Started Jul 2007; status: terminated.
02
Drugs
infliximab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00505947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505947.